Thyroid eye disease: Redefining its management—A review
Amy Patel Jain, Pimkwan Jaru-ampornpan, Raymond S. Douglas
Abstract
Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quality of life. Until recently, the management of TED is a long arduous course with supportive therapy, followed by an extensive surgical treatment plan to reverse the disease endpoints. Teprotumumab offers an early, safe therapeutic intervention to help reverse disease end points such as diplopia and proptosis and improve quality of life.
Topics & Concepts
MedicineDiplopiaDiseaseDisease managementIntervention (counseling)Eye diseaseQuality of life (healthcare)Intensive care medicineThyroidThyroid diseaseOptometrySurgeryPathologyNursingInternal medicineParkinson's diseaseOphthalmology and Eye DisordersCerebral Venous Sinus ThrombosisGlaucoma and retinal disorders